OptimizeRx OPRX Interest Expense
Discontinued — last reported Q1 '26
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's interest expense?
- OptimizeRx (OPRX) reported interest expense of $1.16M in Q1 2026.
- How has OptimizeRx's interest expense changed year-over-year?
- OptimizeRx's interest expense decreased by 10.9% year-over-year, from $1.3M to $1.16M.
- What is the long-term trend for OptimizeRx's interest expense?
- Over 2 years (2023 to 2025), OptimizeRx's interest expense has grown at a 90.8% compound annual growth rate (CAGR), from $1.45M to $5.3M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.